KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects

Diabetes. 2003 Oct;52(10):2639-42. doi: 10.2337/diabetes.52.10.2639.

Abstract

Killer cell immunoglobulin-like receptors (KIRs) modulate natural killer cell and T-cell function by interacting with HLA class 1 ligands on target cells. Both KIR and HLA are highly polymorphic. We studied the influence of KIR and HLA class 1 genes on the susceptibility to develop type 1 diabetes. The results showed increased numbers of activating KIR genes in patients compared with control subjects (P = 0.049). The combination of the activating KIR2DS2 gene, together with its putative HLA ligand, was present more frequently in patients than in diabetes high-risk HLA-matched control subjects (P = 0.030). Moreover, our results imply that an increase in activating KIR2DS2-HLA ligand pairs combined with a lack of inhibitory KIR-HLA ligand pairs is associated with an additional risk to develop type 1 diabetes in individuals with diabetes high-risk HLA alleles (P = 0.035). We propose that the genetic imbalance between KIR and their HLA class 1 ligands may enhance the activation of T-cells with a low affinity for pancreatic self-antigens, thereby contributing to the pathogenesis of type 1 diabetes.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Case-Control Studies
  • Diabetes Mellitus, Type 1 / genetics
  • Diabetes Mellitus, Type 1 / metabolism*
  • Gene Expression Regulation
  • Genetic Predisposition to Disease
  • Histocompatibility Antigens Class I / analysis*
  • Humans
  • Killer Cells, Natural / metabolism*
  • Ligands
  • Receptors, Immunologic / genetics
  • Receptors, Immunologic / metabolism*
  • Receptors, KIR
  • Tissue Distribution

Substances

  • Histocompatibility Antigens Class I
  • KIR2DS2 protein, human
  • Ligands
  • Receptors, Immunologic
  • Receptors, KIR